RVMD logo

Revolution Medicines Inc (RVMD)

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
RVMD
ISIN Code
US76155X1000
Currency
US Dollar (USD)
IPO Date
2020-02-13

Contact Information

Company Address
700 Saginaw Drive, Redwood City, CA, United States, 94063
Contact Phone
650 481 6801
Company Website
https://www.revmed.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$-999,999.99
Return on Assets (TTM)
-30.12%
EBITDA
$-999,999.99
Revenue (TTM)
$742,000